Floatz logo

Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer

Lung Cancer

University of Chicagomonoclonal_antibodyPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
81/ 100

Competitive context

298 Active assets in the Lung Cancer cohort.

Asset / SponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
University of Vermont
Phase 4BB
Carboplatin
SystImmune Inc.
Phase 4BB
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BB
Etoposide
SystImmune Inc.
Phase 3BB
Nivolumab
University of Chicago
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer is also rated in:

urothelial carcinomaDormant
BB
Indicative · Phase 3
68 / 100
View asset →
hepatocellular carcinomaActive
BB
Indicative · Phase 3
65 / 100
View asset →
cancerActive
B
Indicative · Phase 2
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →